Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections Seattle, Washington March 4-7, 2019 Back

Tweet

Hepatitis at CROI 2019: HCV, NASH, HBV; HIV+ MSM Reinfection in NYC; New HCV Cases Sharp Drop in London       CROI: CAN'T BUY ME LOVE? OBSTACLES TO MICRO-ELIMINATION OF ACUTE HCV COINFECTION IN EUROPE - (04/08/19)   CROI: NASH IN HIV - CROI 2019 - (03/05/19)   CROI: Primary HCV in HIV+ MSM: US Epidemic Incidence - (03/12/19)   CROI: Fall in HCV incidence in HIV+ MSM in London following expansion of access to DAA therapy - (03/12/19)   CROI: A PHASE ONE STUDY OF LEDIPASVIR/SOFOSBUVIR IN PREGNANT WOMEN WITH HEPATITIS C VIRUS - (03/12/19)   CROI: Sharp drop in acute HCV among London MSM with HIV after DAAs arrived - (03/15/19)   CROI: RETREATMENT OF HCV IN ADVANCED LIVER DISEASE / CROI 2019 - (03/12/19)   CROI: Real-life efficacy and safety of Glecaprevir/Pibrentasvir in a large cohort of HCV-infected patients: the MISTRAL study - (03/20/19)   CROI: Delayed HCC Diagnosis in HIV/HCV Coinfected: HIV not linked to worse liver cancer survival in people with HCV - (03/26/19)   CROI: Clinical Outcomes in Persons Coinfected with HIV and HCV: Impact of HCV Treatment - (03/07/19)   CROI: Successful HCV treatment does not affect rate of heart disease or non-AIDS cancer - (03/20/19)   CROI: Liver stiffness at SVR predicts hepatic complications in HCV-infected patients - (03/20/19)   CROI: INCIDENT DIABETES AND GLUCOSE CONTROL AFTER HCV TREATMENT WITH DAAS IN ERCHIVES - (03/07/19)   CROI: HCV treatment with DAAs halves risk of new diabetes diagnosis - (03/20/19)   CROI: Inflammation, Arterial Stiffness and Directly-Acting ntivirals in HCV and HIV/HCV, no beneft observed in this study - (03/20/19)   CROI: Effects of eradication of HCV on bone mineral density in HIV/HCV-coinfected patients - Bone density stable over 96 weeks after DAA cure in HIV/HCV group - - (03/07/19)   CROI: Maternal HBV Viremia Is Associated With Adverse Infant Outcomes In HIV/HBV Women: Post-Hoc Analysis of HPTN 046 - (03/20/19)   CROI: Can HBV Be Cured? - "Single hepatocyte analysis in HIV-HBV co-infection shows transcriptional silencing" - (03/22/19)   DAAs:confirmation of their short-term clinical efficacy in "real life" - (02/12/19)   Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study - decrease mortality/ HCC - (02/12/19)   Direct-acting antiviral treatment for hepatitis C - Comment - (02/12/19)